MYO1E and non-small cell lung carcinoma: Univariate Cox proportional hazard analysis showed a higher mortality risk for NSCLC patients harboring higher MYO1E RNA expression compared with lower MYO1E RNA expression (HR 1.74, 95% CI: 1.48–2.05).